VOYA Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Buy |
468,720
+388,146
| +482% | +$16.8M | 0.02% | 529 |
|
|
2025
Q1 | $2.79M | Buy |
80,574
+9,061
| +13% | +$313K | ﹤0.01% | 1171 |
|
|
2024
Q4 | $1.96M | Sell |
71,513
-3,436
| -5% | -$94.3K | ﹤0.01% | 1297 |
|
|
2024
Q3 | $1.91M | Sell |
74,949
-15,815
| -17% | -$403K | ﹤0.01% | 1352 |
|
|
2024
Q2 | $2.3M | Sell |
90,764
-77,212
| -46% | -$1.96M | ﹤0.01% | 1275 |
|
|
2024
Q1 | $5.19M | Sell |
167,976
-25,063
| -13% | -$775K | 0.01% | 983 |
|
|
2023
Q4 | $7.79M | Buy |
193,039
+117,398
| +155% | +$4.74M | 0.01% | 837 |
|
|
2023
Q3 | $1.99M | Buy |
75,641
+29,378
| +64% | +$775K | ﹤0.01% | 1335 |
|
|
2023
Q2 | $796K | Sell |
46,263
-90,680
| -66% | -$1.56M | ﹤0.01% | 1812 |
|
|
2023
Q1 | $2.27M | Buy |
136,943
+95,365
| +229% | +$1.58M | ﹤0.01% | 1306 |
|
|
2022
Q4 | $317K | Hold |
41,578
| – | – | ﹤0.01% | 2301 |
|
|
2022
Q3 | $413K | Hold |
41,578
| – | – | ﹤0.01% | 2148 |
|
|
2022
Q2 | $378K | Hold |
41,578
| – | – | ﹤0.01% | 2010 |
|
|
2022
Q1 | $422K | Hold |
41,578
| – | – | ﹤0.01% | 2006 |
|
|
2021
Q4 | $694K | Sell |
41,578
-482
| -1% | -$8.05K | ﹤0.01% | 1800 |
|
|
2021
Q3 | $1.97M | Sell |
42,060
-319
| -0.8% | -$14.9K | ﹤0.01% | 1182 |
|
|
2021
Q2 | $2.58M | Buy |
42,379
+1,101
| +3% | +$67.1K | 0.01% | 1092 |
|
|
2021
Q1 | $2.54M | Buy |
41,278
+9,590
| +30% | +$591K | 0.01% | 1068 |
|
|
2020
Q4 | $2.25M | Buy |
31,688
+6,646
| +27% | +$473K | ﹤0.01% | 1086 |
|
|
2020
Q3 | $940K | Sell |
25,042
-675
| -3% | -$25.3K | ﹤0.01% | 1320 |
|
|
2020
Q2 | $839K | Sell |
25,717
-11,321
| -31% | -$369K | ﹤0.01% | 1360 |
|
|
2020
Q1 | $1.07M | Buy |
37,038
+26,199
| +242% | +$760K | ﹤0.01% | 1192 |
|
|
2019
Q4 | $380K | Buy |
+10,839
| New | +$380K | ﹤0.01% | 2039 |
|